Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|February 14, 1998
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infectionM J Moran, A Fontanellas, E Brudieux, et al.Journal of Hepatology|July 1, 1990
Ursodeoxycholic acid for primary sclerosing cholangitisO Chazouillères, R Poupon, J P Capron, et al.Journal of Hepatology|November 1, 1994
Prevention of relapse in patients with chronic non-A, non-B/C hepatitis who respond to alpha-interferon. A controlled multicenter trial of low-dose maintenance therapy. Groupe d'Etude Multicentrique de l'Interféron dans les HépatitesD Valla, G Babany, D Ouzan, et al.Gastroenterologie Clinique Et Biologique|April 1, 1995
[Quality of psychomotor recovery after colonoscopy under general anesthesia using propofol. Value of tests of awakening]J M Raymond, E Capdenat, R Beyssac, et al.Dermatologica|January 1, 1991
Porphyria cutanea tarda associated with human immunodeficiency virus infection. A study of four cases and review of the literatureA M Boisseau, P Couzigou, J F Forestier, et al.The New England Journal of Medicine|June 1, 1995
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study GroupT Poynard, P Bedossa, M Chevallier, et al.Gastroenterologie Clinique Et Biologique|September 23, 2008
A French prospective observational study of the treatment of chronic hepatitis C in drug abusersP Chossegros, P Mélin, C Hézode, et al.Hepatology (Baltimore, Md.)|March 1, 1991
Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from FranceP Marcellin, N Boyer, E Giostra, et al.Diabetologia|November 1, 1982
The prevalence of diabetes mellitus and impaired glucose tolerance in Melanesians and part-Polynesians in rural New Caledonia and Ouvea (Loyalty Islands)P Zimmet, D Canteloube, B Genelle, et al.Journal of Viral Hepatitis|January 30, 2009
Changes of non-invasive markers and FibroScan values during HCV treatmentJ Vergniol, J Foucher, L Castéra, et al.Pageof 9